PROVIDER PROFILE · NPI 1023210200

Noridza Rivera-Rodriguez

Hematology-OncologySan Juan, PRI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

304

Beneficiaries

—

Total drug cost

$985K

Distinct drugs

Brand share

37.5%

Top prescribed drugs

Anastrozole59 claims

Levothyroxine Sodium39 claims

Gabapentin23 claims

Ondansetron Hcl21 claims

Enzalutamide15 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$18K

Payment records

119

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$11K

Consulting Fee$5K

Food and Beverage$3K

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 400012

Hospital

CCN 400135

Hospital

REFERRAL NETWORK

Where Noridza Rivera-Rodriguez's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 1 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
HOSPITAL ESPANOL AUXILIO MUTUO DE PUERTO RICO, INC.	19	264

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
HOSPITAL ESPANOL AUXILIO MUTUO DE PUERTO RICO, INC.	20	322

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history